# RYTHM, Inc.: financial statements, quarterly

RYM · Nasdaq · CIK 1800637 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rym.md) · [Financials](/companies/rym/financials.md) · [Filings](/companies/rym/filings.md) · [Insiders](/companies/rym/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rym/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3.1](/filings/0001213900-24-098443.md) | [1.1 d](/filings/0001013762-25-003503.md) | [2.6](/filings/0001213900-24-069066.md) | [3.0](/filings/0001213900-24-069081.md) | [1.9](/filings/0001213900-24-098443.md) | [(7.5) d](/filings/0001213900-26-023069.md) | [0.5](/filings/0001213900-26-052195.md) | [2.0](/filings/0001213900-26-084899.md) | [4.0](/filings/0001213900-25-107368.md) | [10.7 d](/filings/0001213900-26-023069.md) | [13.3](/filings/0001213900-26-052195.md) | [23.0](/filings/0001213900-26-084899.md) |
| Cost of revenue | $m | [2.2](/filings/0001213900-24-098443.md) | [(0.3) d](/filings/0001013762-25-003503.md) | [2.4](/filings/0001213900-24-069066.md) | [1.9](/filings/0001213900-24-069081.md) | [1.7](/filings/0001213900-24-098443.md) | [(5.9) d](/filings/0001213900-26-023069.md) | [0.4](/filings/0001213900-26-052195.md) | [1.4](/filings/0001213900-26-084899.md) | [2.7](/filings/0001213900-25-107368.md) | [2.6 d](/filings/0001213900-26-023069.md) | [2.9](/filings/0001213900-26-052195.md) | [4.5](/filings/0001213900-26-084899.md) |
| Gross profit | $m | [1.0](/filings/0001213900-24-098443.md) | [1.5 d](/filings/0001013762-25-003503.md) | [0.2](/filings/0001213900-24-069066.md) | [1.1](/filings/0001213900-24-069081.md) | [0.2](/filings/0001213900-24-098443.md) | [(1.6) d](/filings/0001213900-26-023069.md) | [0.1](/filings/0001213900-26-052195.md) | [0.7](/filings/0001213900-26-084899.md) | [1.4](/filings/0001213900-25-107368.md) | [8.0 d](/filings/0001213900-26-023069.md) | [10.4](/filings/0001213900-26-052195.md) | [18.5](/filings/0001213900-26-084899.md) |
| Research and development | $m | [0.5](/filings/0001213900-24-098443.md) | [0.4 d](/filings/0001013762-25-003503.md) | [0.3](/filings/0001213900-25-041201.md) | [0.2](/filings/0001213900-25-073302.md) | [0.2](/filings/0001213900-24-098443.md) | [0.1 d](/filings/0001013762-25-003503.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [4.3](/filings/0001213900-24-000433.md) | [(0.0) d](/filings/0001013762-25-003503.md) | [1.6](/filings/0001213900-25-041201.md) | [0.7](/filings/0001213900-25-073302.md) | [1.2](/filings/0001213900-25-107368.md) | [3.4 d](/filings/0001213900-26-023069.md) | [3.8](/filings/0001213900-26-052195.md) | [7.5](/filings/0001213900-26-084899.md) | [10.3](/filings/0001213900-25-107368.md) | [12.5 d](/filings/0001213900-26-023069.md) | [14.4](/filings/0001213900-26-052195.md) | [16.6](/filings/0001213900-26-084899.md) |
| Operating income | $m | [(4.6)](/filings/0001213900-24-098443.md) | [4.5 d](/filings/0001013762-25-003503.md) | [0.4](/filings/0001213900-25-041201.md) | [(0.9)](/filings/0001213900-25-073302.md) | [(1.2)](/filings/0001213900-25-107368.md) | [(3.5) d](/filings/0001213900-26-023069.md) | [(3.7)](/filings/0001213900-26-052195.md) | [(6.8)](/filings/0001213900-26-084899.md) | [(8.9)](/filings/0001213900-25-107368.md) | [(12.9) d](/filings/0001213900-26-023069.md) | [(4.0)](/filings/0001213900-26-052195.md) | [1.9](/filings/0001213900-26-084899.md) |
| Interest expense | $m | not reported | not reported | not reported | [0.0](/filings/0001213900-25-073302.md) | [0.0](/filings/0001213900-25-107368.md) | [0.2 d](/filings/0001213900-26-023069.md) | not reported | [0.5](/filings/0001213900-25-073302.md) | [1.4](/filings/0001213900-25-107368.md) | [1.9 d](/filings/0001213900-26-023069.md) | not reported | [1.7](/filings/0001213900-26-084899.md) |
| Income tax | $m | [(0.9)](/filings/0001213900-24-098443.md) | [0.9 d](/filings/0001013762-25-003503.md) | not reported | [(0.0)](/filings/0001213900-24-069081.md) | [(0.2)](/filings/0001213900-24-098443.md) | [0.2 d](/filings/0001213900-26-023069.md) | not reported | not reported | not reported | not reported | [(25.6)](/filings/0001213900-26-052195.md) | [(1.2)](/filings/0001213900-26-084899.md) |
| Net income | $m | [(2.1)](/filings/0001213900-24-098443.md) | [0.6 d](/filings/0001013762-25-003503.md) | [4.2](/filings/0001213900-25-107368.md) | [(3.0)](/filings/0001213900-25-107368.md) | [(18.7)](/filings/0001213900-25-107368.md) | [(24.4) d](/filings/0001213900-26-023069.md) | [(1.6)](/filings/0001213900-26-084899.md) | [(7.4)](/filings/0001213900-26-084899.md) | [(10.7)](/filings/0001213900-25-107368.md) | [(13.6) d](/filings/0001213900-26-023069.md) | [19.9](/filings/0001213900-26-084899.md) | [1.2](/filings/0001213900-26-084899.md) |
| Diluted EPS | $ per share | [(19.02)](/filings/0001213900-24-098443.md) | not reported | [3.78](/filings/0001213900-25-041201.md) | [(3.16)](/filings/0001213900-25-073302.md) | [(17.28)](/filings/0001213900-25-107368.md) | not reported | [(0.83)](/filings/0001213900-26-052195.md) | [(3.74)](/filings/0001213900-26-084899.md) | [(5.33)](/filings/0001213900-25-107368.md) | not reported | [1.33](/filings/0001213900-26-052195.md) | [0.09](/filings/0001213900-26-084899.md) |
| Basic EPS | $ per share | [(19.02)](/filings/0001213900-24-098443.md) | not reported | [9.21](/filings/0001213900-25-041201.md) | [(3.16)](/filings/0001213900-25-073302.md) | [(17.28)](/filings/0001213900-25-107368.md) | not reported | [(0.83)](/filings/0001213900-26-052195.md) | [(3.74)](/filings/0001213900-26-084899.md) | [(5.33)](/filings/0001213900-25-107368.md) | not reported | [1.53](/filings/0001213900-26-052195.md) | [0.09](/filings/0001213900-26-084899.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | period not labelled (2025-05-20) | Q2 FY2025 (2025-06-30) | period not labelled (2025-08-27) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.1](/filings/0001213900-24-069066.md) | [0.1](/filings/0001213900-24-069081.md) | [0.3](/filings/0001213900-24-098443.md) | [31.2](/filings/0001213900-25-073302.md) | [24.4](/filings/0001213900-25-041201.md) | [5.1](/filings/0001213900-26-023069.md) | [41.0](/filings/0001213900-25-073302.md) | [50.0](/filings/0001213900-26-023069.md) | not reported | [32.2](/filings/0001213900-26-023069.md) | [33.3](/filings/0001213900-26-052195.md) | [41.9](/filings/0001213900-26-084899.md) |
| Current assets | $m | [20.7](/filings/0001213900-24-069066.md) | [20.7](/filings/0001213900-24-069081.md) | [20.8](/filings/0001213900-24-098443.md) | [34.7](/filings/0001213900-26-023069.md) | [27.2](/filings/0001213900-25-041201.md) | not reported | [46.4](/filings/0001213900-25-073302.md) | not reported | [43.9](/filings/0001213900-25-107368.md) | [47.6](/filings/0001213900-26-084899.md) | [46.3](/filings/0001213900-26-052195.md) | [56.4](/filings/0001213900-26-084899.md) |
| Total assets | $m | [40.6](/filings/0001213900-24-069066.md) | [39.4](/filings/0001213900-24-069081.md) | [39.0](/filings/0001213900-24-098443.md) | [54.0](/filings/0001213900-26-023069.md) | [45.6](/filings/0001213900-25-041201.md) | not reported | [69.5](/filings/0001213900-25-073302.md) | not reported | [115](/filings/0001213900-25-107368.md) | [107](/filings/0001213900-26-084899.md) | [128](/filings/0001213900-26-052195.md) | [135](/filings/0001213900-26-084899.md) |
| Current liabilities | $m | [26.7](/filings/0001213900-24-069066.md) | [25.1](/filings/0001213900-24-069081.md) | [27.8](/filings/0001213900-24-098443.md) | [24.7](/filings/0001213900-26-023069.md) | [18.2](/filings/0001213900-25-041201.md) | not reported | [17.5](/filings/0001213900-25-073302.md) | not reported | [22.1](/filings/0001213900-25-107368.md) | [43.0](/filings/0001213900-26-084899.md) | [90.4](/filings/0001213900-26-052195.md) | [95.5](/filings/0001213900-26-084899.md) |
| Total liabilities | $m | [46.1](/filings/0001213900-24-069066.md) | [30.9](/filings/0001213900-24-069081.md) | [33.5](/filings/0001213900-24-098443.md) | [25.9](/filings/0001213900-26-023069.md) | [18.8](/filings/0001213900-25-041201.md) | not reported | [48.5](/filings/0001213900-25-073302.md) | not reported | [103](/filings/0001213900-25-107368.md) | [93.7](/filings/0001213900-26-084899.md) | [90.9](/filings/0001213900-26-052195.md) | [96.3](/filings/0001213900-26-084899.md) |
| Long-term debt | $m | not reported | [4.6](/filings/0001213900-24-069081.md) | [6.2](/filings/0001213900-24-098443.md) | [0.0](/filings/0001213900-26-023069.md) | [10.6](/filings/0001213900-25-041201.md) | not reported | [40.6](/filings/0001213900-25-073302.md) | not reported | [8.0](/filings/0001213900-25-107368.md) | [5.0](/filings/0001213900-26-084899.md) | [80.6](/filings/0001213900-26-052195.md) | [80.6](/filings/0001213900-26-084899.md) |
| Current portion of debt | $m | [0.7](/filings/0001213900-24-069066.md) | [0.6](/filings/0001213900-24-069081.md) | [0.5](/filings/0001213900-24-098443.md) | [0.5](/filings/0001213900-26-023069.md) | [0.6](/filings/0001213900-25-041201.md) | not reported | [0.6](/filings/0001213900-25-073302.md) | not reported | [0.6](/filings/0001213900-25-107368.md) | [3.6](/filings/0001213900-26-084899.md) | [8.6](/filings/0001213900-26-052195.md) | [8.6](/filings/0001213900-26-084899.md) |
| Shareholders' equity | $m | [(5.5)](/filings/0001213900-25-107368.md) | [8.5](/filings/0001213900-25-107368.md) | [5.5](/filings/0001213900-25-107368.md) | [28.1](/filings/0001213900-26-084899.md) | [26.8](/filings/0001213900-26-084899.md) | not reported | [21.0](/filings/0001213900-26-084899.md) | not reported | [11.7](/filings/0001213900-25-107368.md) | [13.0](/filings/0001213900-26-084899.md) | [36.6](/filings/0001213900-26-084899.md) | [39.1](/filings/0001213900-26-084899.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt, us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(14.3) d](/filings/0001213900-24-098443.md) | [(5.0) d](/filings/0001013762-25-003503.md) | [(3.0)](/filings/0001213900-25-041201.md) | [(1.8) d](/filings/0001213900-25-073302.md) | [(1.4) d](/filings/0001213900-25-107368.md) | [(5.3) d](/filings/0001213900-26-023069.md) | [(6.7)](/filings/0001213900-26-052195.md) | [(8.4) d](/filings/0001213900-26-084899.md) | [(5.4) d](/filings/0001213900-25-107368.md) | [(3.0) d](/filings/0001213900-26-023069.md) | [1.0](/filings/0001213900-26-052195.md) | [8.7 d](/filings/0001213900-26-084899.md) |
| Capital expenditure | $m | [(0.0) d](/filings/0001213900-24-098443.md) | [0.0 d](/filings/0001013762-25-003503.md) | [0.0](/filings/0001213900-25-041201.md) | [0.0 d](/filings/0001213900-25-073302.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [134](/filings/0001213900-24-000433.md) | [1,072](/filings/0001213900-24-069066.md) | [1,550](/filings/0001213900-24-069081.md) | [110](/filings/0001213900-24-098443.md) | [1,198](/filings/0001213900-25-041201.md) | [941](/filings/0001213900-25-073302.md) | [1,079](/filings/0001213900-25-107368.md) | [1,952](/filings/0001213900-26-052195.md) | [1,965](/filings/0001213900-26-084899.md) | [2,003](/filings/0001213900-25-107368.md) | [5,247](/filings/0001213900-26-052195.md) | [2,284](/filings/0001213900-26-084899.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 2,179,128 at 2026-08-04, from the cover of the [10-Q filed 2026-08-04](/filings/0001213900-26-084899.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.